Policy & Medicine

Legal, Regulatory, and Compliance Issues

facebook
twitter
google_plus
Email

Browsing daily archive

January 4, 2019

PhRMA Submits Comments on CMS Proposed Regulation to Require Drug Pricing Transparency

Open Payments
Litigation
FDA
CME
Opioids
International
State Policy
Transparency
COVID-19
CMS
MACRA

View Desktop Version